APPLICATION
ANDA075582
TYPE
ANDA
ORIGINAL APPROVAL
2001-02-23
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DICLOFENAC POTASSIUMDiscontinued
DICLOFENAC POTASSIUM 50MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 8 · standardAP
2023-11-20Labeling · Supplement 7 · standardAP
2021-04-28Labeling · Supplement 5 · standardAP
2021-03-31Labeling · Supplement 4 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.